Showing results (1-10 of 144) with videos related to
Sort By:
Pageof 15
Cardiac Electrophysiology Review|January 24, 2004
Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trialCheuk-Kit Wong, Harvey D White, Robert G Wilcox, et al.Cardiac Electrophysiology Review|January 24, 2004
Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) studySteven N SinghCardiac Electrophysiology Review|January 24, 2004
Beta-blocker efficacy according to heart rate and rhythm in patients with heart failure. Commentary on the Cardiac Insufficiency Bisoprolol Study II analysisPhilippe P LechatCardiac Electrophysiology Review|January 24, 2004
Left versus bi-atrial intraoperative saline-irrigated radiofrequency modified maze procedure for atrial fibrillationMustafa Guden, Belhhan Akpinar, Baris Caynak, et al.Cardiac Electrophysiology Review|January 24, 2004
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)John Wikstrand, Hans Wedel, Jalal Ghali, et al.Cardiac Electrophysiology Review|January 24, 2004
Time to first recurrence as a trial endpoint: time to change?Rahul MehraCardiac Electrophysiology Review|April 9, 2004
Detection of atrial fibrillation by permanent pacemakers: observations from the STOP AF trialC J Plummer, J M McComb, Cardiac Electrophysiology Review|April 9, 2004
Atrial fibrillation: should we target platelets or the coagulation pathway?Kiat T Tan, Gregory Y H LipCardiac Electrophysiology Review|April 9, 2004
Use of subcutaneous enoxaparin compared to intravenous heparin and oral phenprocoumon in the setting of cardioversion--the ACE study (Anticoagulation in Cardioversion using Enoxaparin)Christoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, et al.Cardiac Electrophysiology Review|April 9, 2004
Low molecular weight heparin in atrial fibrillation management: facts, fiction, futureMichael H Kim, Richard G Trohman, Kim A EaglePageof 15